VIATRIS INC. (VTRS) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
22/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinVTRS / S&P 18.41% / 15.20% |
LoseVTRS / S&P 4.47% / 15.00% |
LoseVTRS / S&P -87.59% / 50.40% |
| 2026-Q11/3 |
WinVTRS / S&P 9.44% / -4.33% |
LoseVTRS / S&P 1.64% / 11.30% |
LoseVTRS / S&P -91.80% / 27.70% |
| 2025-Q42/3 |
WinVTRS / S&P 27.22% / 2.65% |
LoseVTRS / S&P -3.01% / 9.00% |
WinVTRS / S&P 458.49% / 13.40% |
| 2025-Q32/3 |
WinVTRS / S&P 12.12% / 8.12% |
LoseVTRS / S&P -6.19% / 4.61% |
WinVTRS / S&P 323.29% / 13.45% |
| 2025-Q21/3 |
LoseVTRS / S&P 3.99% / 10.94% |
LoseVTRS / S&P -7.46% / 4.83% |
WinVTRS / S&P 437.04% / 10.63% |
| 2025-Q11/3 |
LoseVTRS / S&P -29.16% / -4.27% |
LoseVTRS / S&P -6.79% / 4.98% |
WinVTRS / S&P 6240.00% / 10.57% |
| 2024-Q41/3 |
WinVTRS / S&P 8.22% / 2.41% |
LoseVTRS / S&P -4.52% / 5.25% |
LoseVTRS / S&P -1160.00% / 6.15% |
| 2024-Q31/3 |
WinVTRS / S&P 10.35% / 5.89% |
LoseVTRS / S&P -2.76% / 5.89% |
LoseVTRS / S&P -148.34% / 6.11% |
| 2024-Q20/3 |
LoseVTRS / S&P -9.98% / 4.28% |
LoseVTRS / S&P -2.34% / 5.38% |
LoseVTRS / S&P -135.29% / 5.12% |
| 2024-Q11/3 |
WinVTRS / S&P 11.33% / 10.56% |
LoseVTRS / S&P -2.77% / 5.71% |
LoseVTRS / S&P -103.18% / 5.59% |
| 2023-Q40/3 |
LoseVTRS / S&P 11.26% / 11.69% |
LoseVTRS / S&P -5.12% / 6.81% |
LoseVTRS / S&P -97.08% / 7.78% |
| 2023-Q32/3 |
WinVTRS / S&P -0.13% / -3.27% |
LoseVTRS / S&P -7.51% / 7.52% |
WinVTRS / S&P 128.79% / -5.03% |
| 2023-Q21/3 |
LoseVTRS / S&P 5.07% / 8.74% |
LoseVTRS / S&P -9.18% / 9.50% |
WinVTRS / S&P 142.86% / -8.57% |
| 2023-Q11/3 |
LoseVTRS / S&P -12.59% / 7.50% |
LoseVTRS / S&P -10.42% / 10.77% |
WinVTRS / S&P 1021.43% / -15.69% |
| 2022-Q41/3 |
WinVTRS / S&P 32.06% / 7.56% |
LoseVTRS / S&P -8.96% / 11.88% |
LoseVTRS / S&P -262.86% / -17.99% |
| 2022-Q30/3 |
LoseVTRS / S&P -17.67% / -4.88% |
LoseVTRS / S&P -2.27% / 13.47% |
LoseVTRS / S&P -127.27% / -1.41% |
| 2022-Q21/3 |
WinVTRS / S&P -2.78% / -16.10% |
LoseVTRS / S&P 10.57% / 13.71% |
LoseVTRS / S&P -127.16% / 11.04% |
| 2022-Q11/3 |
LoseVTRS / S&P -18.92% / -4.60% |
WinVTRS / S&P 29.05% / 15.97% |
LoseVTRS / S&P -106.97% / 42.23% |
| 2021-Q41/3 |
LoseVTRS / S&P 0.70% / 11.03% |
WinVTRS / S&P 50.71% / 15.00% |
LoseVTRS / S&P -5.41% / 96.40% |
| 2021-Q30/3 |
LoseVTRS / S&P -4.46% / 0.58% |
LoseVTRS / S&P VTRS unavailable / 10.77% |
LoseVTRS / S&P VTRS unavailable / 69.42% |
| 2021-Q20/3 |
LoseVTRS / S&P 3.02% / 8.55% |
LoseVTRS / S&P VTRS unavailable / 6.58% |
LoseVTRS / S&P VTRS unavailable / 51.81% |
| 2021-Q10/3 |
LoseVTRS / S&P -25.45% / 6.17% |
LoseVTRS / S&P VTRS unavailable / -1.06% |
LoseVTRS / S&P VTRS unavailable / 7.39% |
| 2020-Q41/3 |
WinVTRS / S&P 26.37% / 12.15% |
LoseVTRS / S&P VTRS unavailable / -3.72% |
LoseVTRS / S&P VTRS unavailable / -33.42% |
| 2020-Q30/3 |
LoseVTRS / S&P -7.77% / 8.93% |
LoseVTRS / S&P VTRS unavailable / -2.04% |
LoseVTRS / S&P VTRS unavailable / -27.10% |
| 2020-Q20/3 |
LoseVTRS / S&P 7.85% / 20.54% |
LoseVTRS / S&P VTRS unavailable / -0.46% |
LoseVTRS / S&P VTRS unavailable / -27.11% |
| 2020-Q10/3 |
LoseVTRS / S&P -25.82% / -19.60% |
LoseVTRS / S&P VTRS unavailable / 3.47% |
LoseVTRS / S&P VTRS unavailable / -14.75% |
| 2019-Q40/3 |
LoseVTRS / S&P 1.62% / 9.07% |
LoseVTRS / S&P VTRS unavailable / 5.36% |
LoseVTRS / S&P VTRS unavailable / 2.99% |
| 2019-Q31/3 |
WinVTRS / S&P 3.89% / 1.70% |
LoseVTRS / S&P VTRS unavailable / 5.02% |
LoseVTRS / S&P VTRS unavailable / 0.21% |
| 2019-Q20/3 |
LoseVTRS / S&P -32.82% / 4.30% |
LoseVTRS / S&P VTRS unavailable / 6.64% |
LoseVTRS / S&P VTRS unavailable / 8.65% |
| 2019-Q10/3 |
LoseVTRS / S&P 3.43% / 13.65% |
LoseVTRS / S&P VTRS unavailable / 8.12% |
LoseVTRS / S&P VTRS unavailable / 14.29% |
| 2018-Q40/3 |
LoseVTRS / S&P -25.14% / -13.52% |
LoseVTRS / S&P VTRS unavailable / 9.05% |
LoseVTRS / S&P VTRS unavailable / 18.23% |
| 2018-Q30/3 |
LoseVTRS / S&P 1.27% / 7.71% |
LoseVTRS / S&P VTRS unavailable / 10.21% |
LoseVTRS / S&P VTRS unavailable / 19.06% |
| 2018-Q20/3 |
LoseVTRS / S&P -12.22% / 3.43% |
LoseVTRS / S&P VTRS unavailable / 9.03% |
LoseVTRS / S&P VTRS unavailable / 14.46% |
| 2018-Q10/3 |
LoseVTRS / S&P -2.69% / -0.76% |
LoseVTRS / S&P VTRS unavailable / 7.68% |
LoseVTRS / S&P VTRS unavailable / 12.46% |
| 2017-Q41/3 |
WinVTRS / S&P 34.87% / 6.64% |
LoseVTRS / S&P VTRS unavailable / 7.03% |
LoseVTRS / S&P VTRS unavailable / 13.82% |
| 2017-Q30/3 |
LoseVTRS / S&P -19.19% / 4.48% |
LoseVTRS / S&P VTRS unavailable / 5.68% |
LoseVTRS / S&P VTRS unavailable / 17.57% |
| 2017-Q20/3 |
LoseVTRS / S&P -0.44% / 3.09% |
LoseVTRS / S&P VTRS unavailable / 4.83% |
LoseVTRS / S&P VTRS unavailable / 17.74% |
| 2017-Q10/3 |
LoseVTRS / S&P 2.20% / 6.07% |
LoseVTRS / S&P VTRS unavailable / 3.67% |
LoseVTRS / S&P VTRS unavailable / 13.32% |
| 2016-Q40/3 |
LoseVTRS / S&P 0.08% / 3.82% |
LoseVTRS / S&P VTRS unavailable / 2.09% |
LoseVTRS / S&P VTRS unavailable / 7.05% |
| 2016-Q30/3 |
LoseVTRS / S&P -11.84% / 3.85% |
LoseVTRS / S&P VTRS unavailable / 0.20% |
LoseVTRS / S&P VTRS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VTRS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 65.77% | 20.78% |
| Annualized return | 65.77% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VTRS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 42.86% | 83.14% |
| Annualized return | 7.39% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | VTRS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -49.55% | 319.30% |
| Annualized return | -6.61% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |